ARIC BARRIOS: Open Payments
NPI 1407300817 · ATHENS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,450 in 109 payments from 13 companies in 2025. Trend: 2023 $1,265 · 2024 $1,905 · 2025 $2,450
Food & beverage: $2,450
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 58 | $1,224 |
| Janssen Biotech, Inc. | 7 | $253 |
| EVOKE PHARMA, INC. | 11 | $201 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $158 |
| GENZYME CORPORATION | 5 | $133 |
| Novo Nordisk Inc | 2 | $128 |
| Phathom Pharmaceuticals, Inc. | 6 | $98 |
| VIVUS LLC | 3 | $59 |
| Gilead Sciences, Inc. | 2 | $51 |
| Ardelyx, Inc. | 2 | $50 |
Products named: LINZESS, RINVOQ, TREMFYA, GIMOTI, SKYRIZI, CREON, DUPIXENT, Wegovy.
Industry payments across TX — which companies pay providers there.
